Monday, 21 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Finance
  • Clinical trial results
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

China’s Cecolin HPV Vaccine Shows 100% Efficacy in 66-Month Study

February 10, 2025
CompanyDrug

Dizal Pharma’s Sunvozertinib Gains NMPA Approval for EGFR Mutation NSCLC Trial

February 10, 2025
CompanyPolicy / Regulatory

MofCOM’s 2021 Pharma Distribution Report Shows Market Recovery

February 10, 2025
Policy / Regulatory

NHSA Issues Notice on Special Treatment of Oral Implant Medical Service Charges

February 10, 2025
CompanyDrug

Keymed and Lepu’s CMG901 Receives Breakthrough Therapy Designation for Gastric Cancer

February 11, 2025
CompanyDeals

Realcan Pharma and AWS Expand Partnership for Digital Transformation

February 10, 2025
CompanyLegal / IP

Salipro Biotech Secures Patent Protection for Membrane Protein Stabilization Tech

February 10, 2025
CompanyDrug

Sirnaomics Initiates Phase I Study of STP705 for Abdominal Fat Reduction

January 31, 2025
Company

China Pharma H1 2022 Financials: 40% of Firms Report Revenue and Profit Growth

August 26, 2025
CompanyDeals

Suzhou InnoBM Pharmaceuticals Raises Series A+ Funding for Tumor Immunotherapy

February 10, 2025
CompanyDrug

Laekna Therapeutics Doses First Patient in LAE001/LAE002 Study for Prostate Cancer

February 10, 2025
Policy / Regulatory

NHSA Reveals Drugs Passing Initial Review for NRDL Inclusion

February 10, 2025
1 2 … 12 13 14 15 16 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up